These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 11266524)
1. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Kleer CG; Giordano TJ; Braun T; Oberman HA Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524 [TBL] [Abstract][Full Text] [Related]
2. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772 [TBL] [Abstract][Full Text] [Related]
3. p53 protein expression and gene mutation in phyllodes tumors of the breast. Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782 [TBL] [Abstract][Full Text] [Related]
4. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast. Kucuk U; Bayol U; Pala EE; Cumurcu S Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649 [TBL] [Abstract][Full Text] [Related]
5. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast. Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904 [TBL] [Abstract][Full Text] [Related]
6. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328 [TBL] [Abstract][Full Text] [Related]
7. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumor of the prostate: long-term followup study of 23 cases. Bostwick DG; Hossain D; Qian J; Neumann RM; Yang P; Young RH; di Sant'agnese PA; Jones EC J Urol; 2004 Sep; 172(3):894-9. PubMed ID: 15310992 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905 [TBL] [Abstract][Full Text] [Related]
10. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors. Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808 [TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Kleer CG; Giordano TJ; Merino MJ Mod Pathol; 2000 Jul; 13(7):742-6. PubMed ID: 10912933 [TBL] [Abstract][Full Text] [Related]
12. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517 [TBL] [Abstract][Full Text] [Related]
13. Multinucleated stromal giant cells in mammary phyllodes tumours. Tse GM; Law BK; Chan KF; Mas TK Pathology; 2001 May; 33(2):153-6. PubMed ID: 11358046 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast. Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883 [TBL] [Abstract][Full Text] [Related]
17. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797 [TBL] [Abstract][Full Text] [Related]
20. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]